or Try an Advanced Search...

    Technical Analysis for DBVT - DBV Technologies S.A.

    Grade Last Price % Change Price Change
    F 0.51 3.46% 0.02
    DBVT closed up 3.46 percent on Wednesday, November 20, 2024, on 9 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical DBVT trend table...
    Date Alert Name Type % Chg
    Jack-in-the-Box Bearish Bearish Swing Setup 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 3.46%
    Expansion Breakdown Bearish Swing Setup 3.46%
    Wide Range Bar Range Expansion 3.46%
    Lower Bollinger Band Walk Weakness 3.46%
    New 52 Week Low Weakness 3.46%
    Wide Bands Range Expansion 3.46%
    Older End-of-Day Signals for DBVT ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Lower Bollinger Band about 21 hours ago
    Up 3% about 21 hours ago
    Up 2% about 21 hours ago
    Up 1% about 21 hours ago
    Gap Up Closed 1 day ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    DBVT Chart by TradingView
    Basic chart:

    Profile

    DBV Technologies S.A. is engaged in the research, development, and marketing of products for the diagnosis and treatment of allergies, primarily food allergies in young children. The company provides Diallertest, a non-invasive patch allergy diagnostic for infants, children, or adults for the diagnosis of allergy in cow milk, wheat, and soybean. Its products include Viaskin Peanut, an immunotherapy product for the treatment of patients with peanut allergies; Viaskin Milk, for the treatment of CMPA and eosinophilic esophagitis, as well as food polyallergies; and Viaskin House Dust Mite, a mite desensitization product for the treatment of mite allergy. The company was founded in 2002 and is based in Bagneux, France.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Immunology Immune System Immunotherapy Soybean Wheat Allergy Milk Immunotherapy Products Peanut Allergies Allergology Eosinophil

    Is DBVT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 7 DBV Technologies’ stock slides as financial woes worsens
    Nov 7 DBV Technologies GAAP EPS of -$0.32 beats by $0.03
    Oct 23 Penny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway
    Oct 23 Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
    Sep 23 DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
    Aug 2 Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024
    Jul 31 DBV Technologies S.A. (DBVT) Q2 2024 Earnings Call Transcript
    Jul 30 DBV Technologies Announces Filing of 2024 Half-Year Report ― Conditions for Accessing or Consulting the Report
    Jul 30 DBV Technologies Provides Updates on the Viaskin Peanut Program in Children and Toddlers and Reports Second Quarter and Half-Year 2024 Financial Results
    Jul 29 DBV Technologies to Report Second Quarter 2024 Financial Results and Business Update on July 30, 2024
    See more DBVT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.12
    52 Week Low 0.4409
    Average Volume 802,400
    200-Day Moving Average 1.08
    50-Day Moving Average 0.70
    20-Day Moving Average 0.70
    10-Day Moving Average 0.60
    Average True Range 0.07
    RSI (14) 30.07
    ADX 28.43
    +DI 11.13
    -DI 29.45
    Chandelier Exit (Long, 3 ATRs) 0.87
    Chandelier Exit (Short, 3 ATRs) 0.66
    Upper Bollinger Bands 0.93
    Lower Bollinger Band 0.47
    Percent B (%b) 0.09
    BandWidth 66.14
    MACD Line -0.06
    MACD Signal Line -0.03
    MACD Histogram -0.0259
    Fundamentals Value
    Market Cap 97.73 Million
    Num Shares 192 Million
    EPS -0.55
    Price-to-Earnings (P/E) Ratio -0.92
    Price-to-Sales 31.60
    Price-to-Book 1.14
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.58
    Resistance 3 (R3) 0.58 0.55 0.57
    Resistance 2 (R2) 0.55 0.53 0.55 0.57
    Resistance 1 (R1) 0.53 0.52 0.53 0.53 0.56
    Pivot Point 0.50 0.50 0.50 0.50 0.50
    Support 1 (S1) 0.48 0.48 0.48 0.48 0.45
    Support 2 (S2) 0.45 0.47 0.45 0.45
    Support 3 (S3) 0.43 0.45 0.44
    Support 4 (S4) 0.43